113 related articles for article (PubMed ID: 8611960)
21. Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.
Ueda T; Nakamura T; Kagawa D; Uchida M; Domae N; Sugiyama M; Ueda Y; Sasada M; Uchino H
Cancer Chemother Pharmacol; 1989; 24(6):371-5. PubMed ID: 2791191
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
[TBL] [Abstract][Full Text] [Related]
23. Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
Koller-Lucae SK; Schott H; Schwendener RA
Br J Cancer; 1999 Jul; 80(10):1542-9. PubMed ID: 10408395
[TBL] [Abstract][Full Text] [Related]
24. Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography.
Loos WJ; van Zomeren DM; Gelderblom H; Verweij J; Nooter K; Stoter G; Sparreboom A
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):99-105. PubMed ID: 11820300
[TBL] [Abstract][Full Text] [Related]
25. Highly sensitive high-performance liquid chromatographic assay for 1-beta-D-arabinofuranosylcytosine-5'-stearyl phosphate (cytarabine-ocfosfate).
Ramsauer B; Braess J; Unterhalt M; Kaufmann CC; Hiddemann W; Schleyer E
J Chromatogr B Biomed Appl; 1995 Mar; 665(1):183-92. PubMed ID: 7795790
[TBL] [Abstract][Full Text] [Related]
26. Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.
Wang Z; Wang H; Rhie JK; Covey JM; Liang P; Wang S; Wang C; Hu Y; Prasad G; Nan L; Hill DL; Zhang R
J Pharm Biomed Anal; 2006 Sep; 42(2):272-6. PubMed ID: 16616824
[TBL] [Abstract][Full Text] [Related]
27. Incorporation of N4-behenoyl-1-beta-D-arabinofuranosylcytosine into DNA as 1-beta-D-arabinofuranosylcytosine.
Higashigawa M; Ochiai H; Ohkubo T; Kawasaki H; Nobori T; Kamiya H; Sakurai M
Med Oncol Tumor Pharmacother; 1988; 5(4):265-71. PubMed ID: 2848163
[TBL] [Abstract][Full Text] [Related]
28. Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model.
Schwendener RA; Schott H
J Cancer Res Clin Oncol; 1996; 122(12):723-6. PubMed ID: 8954169
[TBL] [Abstract][Full Text] [Related]
29. Determination of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil in human plasma by high-performance liquid chromatography.
Linssen P; Drenthe-Schonk A; Wessels H; Haanen C
J Chromatogr; 1981 May; 223(2):371-8. PubMed ID: 7251792
[TBL] [Abstract][Full Text] [Related]
30. Intracellular pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Higashigawa M; Hori H; Ochiai H; Ohkubo T; Kawasaki H; Nobori T; Kamiya H; Sakurai M
Adv Exp Med Biol; 1989; 253B():341-8. PubMed ID: 2610121
[No Abstract] [Full Text] [Related]
31. Simultaneous determination of cytosine arabinoside and its metabolite, uracil arabinoside, in human plasma using hydrophilic interaction liquid chromatography with UV detection.
Uchiyama M; Takamatsu Y; Ogata K; Matsumoto T; Jimi S; Tamura K; Hara S
Biomed Chromatogr; 2013 Jul; 27(7):818-20. PubMed ID: 23420764
[TBL] [Abstract][Full Text] [Related]
32. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
33. High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides.
Sinkule JA; Evans WE
J Chromatogr; 1983 May; 274():87-93. PubMed ID: 6575975
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
[TBL] [Abstract][Full Text] [Related]
35. Alkylsulphonic acid ion pairing with radial compression columns for determining plasma or cerebrospinal fluid 1-beta-D-arabinofuranosylcytosine in pediatric pharmacokinetic analysis.
Stout ML; Ravindranath Y
J Chromatogr A; 1995 Feb; 692(1-2):59-66. PubMed ID: 7719461
[TBL] [Abstract][Full Text] [Related]
36. In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
Chemotherapy; 1989; 35(3):181-6. PubMed ID: 2766858
[TBL] [Abstract][Full Text] [Related]
37. Determination of anticancer drug vitamin K3 in plasma by high-performance liquid chromatography.
Hu OY; Wu CY; Chan WK; Wu FY
J Chromatogr B Biomed Appl; 1995 Apr; 666(2):299-305. PubMed ID: 7633606
[TBL] [Abstract][Full Text] [Related]
38. Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatography.
Rentsch KM; Schwendener RA; Hänseler E
J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):185-92. PubMed ID: 8998559
[TBL] [Abstract][Full Text] [Related]
39. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs.
Rosowsky A; Kim SH; Ross J; Wick MM
J Med Chem; 1982 Feb; 25(2):171-8. PubMed ID: 7057424
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous determination of cytosine arabinoside, its nucleotides and metabolites by ion-pair high-performance liquid chromatography.
Schilsky RL; Ordway FS
J Chromatogr; 1985 Jan; 337(1):63-71. PubMed ID: 3980658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
